These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2377651)

  • 21. Blockade of both D1- and D2-dopamine receptors inhibits amphetamine-induced ascorbate release in the neostriatum.
    Oh C; Gardiner TW; Rebec GV
    Brain Res; 1989 Feb; 480(1-2):184-9. PubMed ID: 2565749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atypical antipsychotic drugs block selective components of amphetamine-induced stereotypy.
    Tschanz JT; Rebec GV
    Pharmacol Biochem Behav; 1988 Nov; 31(3):519-22. PubMed ID: 3251235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bilateral cortical ablations attenuate amphetamine-induced excitations of neostriatal motor-related neurons in freely moving rats.
    Tschanz JT; Haracz JL; Griffith KE; Rebec GV
    Neurosci Lett; 1991 Dec; 134(1):127-30. PubMed ID: 1815145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous electrochemical and unit recording measurements: characterization of the effects of D-amphetamine and ascorbic acid on neostriatal neurons.
    Ewing AG; Alloway KD; Curtis SD; Dayton MA; Wightman RM; Rebec GV
    Brain Res; 1983 Feb; 261(1):101-8. PubMed ID: 6301620
    [No Abstract]   [Full Text] [Related]  

  • 25. Amphetamine promotes neostriatal ascorbate release via a nigro-thalamo-cortico-neostriatal loop.
    Pierce RC; Clemens AJ; Grabner CP; Rebec GV
    J Neurochem; 1994 Oct; 63(4):1499-507. PubMed ID: 7931303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of neostriatal activity by iontophoresis of ascorbic acid.
    Gardiner TW; Armstrong-James M; Caan AW; Wightman RM; Rebec GV
    Brain Res; 1985 Sep; 344(1):181-5. PubMed ID: 2864108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of sulpiride on amphetamine-induced behaviour in relation to changes in striatal dopamine release in vivo.
    Sharp T; Zetterström T; Ljungberg T; Ungerstedt U
    Eur J Pharmacol; 1986 Oct; 129(3):411-5. PubMed ID: 3780853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. D-amphetamine administration reduces substance P concentration in the rat striatum.
    Pettibone DJ; Wurtman RJ; Leeman SE
    Biochem Pharmacol; 1978 Mar; 27(5):839-12. PubMed ID: 656130
    [No Abstract]   [Full Text] [Related]  

  • 29. A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis.
    Sharp T; Zetterström T; Ljungberg T; Ungerstedt U
    Brain Res; 1987 Jan; 401(2):322-30. PubMed ID: 3815099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of chronic atypical antipsychotic drugs and haloperidol on amphetamine-induced dopamine release in vivo.
    Ichikawa J; Meltzer HY
    Brain Res; 1992 Mar; 574(1-2):98-104. PubMed ID: 1379112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cortical lesions attenuate the opposing effects of amphetamine and haloperidol on neostriatal neurons in freely moving rats.
    Tschanz JT; Griffith KE; Haracz JL; Rebec GV
    Eur J Pharmacol; 1994 May; 257(1-2):161-7. PubMed ID: 8082698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amphetamine behavioral toxicity: rotational behavior after chronic intrastriatal infusion.
    Dougherty GG; Ellinwood EH
    Biol Psychiatry; 1981 May; 16(5):479-88. PubMed ID: 7196774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential inhibitory effects of ascorbic acid on the binding of dopamine agonists and antagonists to neostriatal membrane preparations: correlations with behavioral effects.
    Heikkila RE; Cabbat FS; Manzino L
    Res Commun Chem Pathol Pharmacol; 1981 Dec; 34(3):409-21. PubMed ID: 7323442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concurrent on-line analysis of striatal ascorbate, dopamine and dihydroxyphenylacetic acid concentrations by in vivo voltammetry.
    Gonzalez-Mora JL; Sanchez-Bruno JA; Mas M
    Neurosci Lett; 1988 Mar; 86(1):61-6. PubMed ID: 3362430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Some behavioural and EEG effects of ascorbic acid in rats.
    Wambebe C; Sokomba E
    Psychopharmacology (Berl); 1986; 89(2):167-70. PubMed ID: 3088632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ascorbate modulation of sensorimotor processing in striatum of freely moving rats.
    Cortright JJ; Rebec GV
    Brain Res; 2006 May; 1092(1):108-16. PubMed ID: 16753136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose-dependent biphasic alterations in the spontaneous activity of neurons in the rat neostriatum produced by d-amphetamine and methylphenidate.
    Rebec GV; Segal DS
    Brain Res; 1978 Jul; 150(2):353-66. PubMed ID: 567085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydroxyl radical generation dependent on extracellular ascorbate in rat striatum, as determined by microdialysis.
    Hara S; Mizukami H; Kuriiwa F; Endo T
    Toxicology; 2009 Apr; 258(1):10-6. PubMed ID: 19167451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity.
    Obuchowicz E; Krysiak R; Wieronska JM; Smialowska M; Herman ZS
    Neuropeptides; 2005 Oct; 39(5):515-23. PubMed ID: 16154634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrophysiological and behavioral output of the rat basal ganglia after intrastriatal infusion of d-amphetamine: lack of support for the basal ganglia model.
    Waszczak BL; Martin L; Boucher N; Zahr N; Sikes RW; Stellar JR
    Brain Res; 2001 Nov; 920(1-2):170-82. PubMed ID: 11716823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.